Guided ICBT for Adults With Tinnitus in Canada: A Randomized Controlled Trial

ConditionTinnitus
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-79
SponsorWestern University, Canada

About this trial

The goal of this randomized controlled trial is to learn if guided Internet-delivered Cognitive Behavioural Therapy can treat tinnitus-related distress and its associated comorbidities such as anxiety, depression, insomnia, and quality of life among adult tinnitus patients in Canada. The main questions it aims to answer are:

* Does guided internet-delivered cognitive behavioural therapy for the treatment of tinnitus reduce tinnitus-related distress and tinnitus-associated comorbidities (depression, anxiety, insomnia, quality of life) among adult tinnitus patients aged 18-79 years in Canada from pre-treatment to post-treatment and 3-month follow-up? * Do participants in the personalized ICBT treatment group show worse improvements in patient-reported outcomes from pre-treatment to post-treatment and 3-month follow-up than the standard ICBT control group?

The researchers will compare a personalized ICBT program to a standard ICBT program to investigate if participants in the personalized ICBT program will show no worse improvements in patient-reported outcomes from pre-treatment to post-treatment and 3-month follow-up than the active comparator, the standard ICBT program.

Participants will:

* Receive either a personalized ICBT program or a standard ICBT program delivered over 8 weeks consisting of 21 modules. * Receive guided support of approximately 10-15 minutes per week by video chat or phone from a trained Guide over the 8-week duration of the program. * Complete assessments at baseline, post-intervention, and 3-month follow-up through online REDCap surveys with automatic emails and telephone reminders.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adults (18-79 years);

diagnosed with tinnitus for more than 6 months;

ability to read and write in English;

cognitive capacity to consent and participate in the therapeutic process;

Disqualifiers

have significant cognitive impairments that impact their ability to participate in the therapy;

are currently involved in another psychotherapeutic intervention on a regular basis;

present with severe mental health disorder that would be better treated in person (e.g., severe suicide ideation, severe substance abuse, recent history of psychosis, mania);

have tinnitus as a consequence of a medical disorder, still under investigation;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Internet Delivered Cognitive Behavioural Therapy

    Behavioral

    The tinnitus ICBT program consists of 1) an overview of tinnitus, depression, and anxiety; 2) managing unhelpful thoughts and learning problem solving strategies association with pain, anxiety, depression, and disability; 3) management of common symptoms associated with tinnitus, anxiety, and depression; 4) developing strategies to maintain activities while minimizing fatigue; and 5) strategies to improve quality of life through effective goal setting. Supplementary lessons can be accessed at any time (e.g., sleep, communication, problem solving, assertiveness training). Materials are presented in a didactic (i.e., text-based and audio with visual images) and case-enhanced learning format (i.e., stories demonstrate the application of skills). Case vignettes that specifically reflect the experiences of those with tinnitus are included.

Treatment groups

82 Participants
are divided into 2 treatment groups
Group A: Personalized ICBTExperimental treatment 1 intervention
Group B: Standard ICBTActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Tinnitus distress

The primary assessment measure to quantify distress will be the Tinnitus Functional Index (TFI). A 13-point change in TFI scores will be identified as a clinically meaningful/significant change. Low scores indicate low severity and high scores indicate high severity.

Time frame
baseline, post-treatment and 3-month follow-up

Secondary outcomes

1

Depression

The Patient Health Questionnaire-9 (PHQ-9) will be used to measure depression. Low scores indicate low severity and high scores indicate high severity.

Time frame
baseline, post-treatment and 3-month follow-up
2

Anxiety

Generalized Anxiety Disorder-7 (GAD-7) will be used to measure anxiety. Low scores indicate low severity and high scores indicate high severity.

Time frame
baseline, post-treatment and 3-month follow-up
3

Insomnia

Insomnia Severity Index (ISI) will be used to measure insomnia. Low scores indicate low severity and high scores indicate high severity.

Time frame
baseline, post-treatment and 3-month follow-up
4

Satisfaction with life

Satisfaction with Life Scales (SWLS) for satisfaction with life will be used to measure satisfaction with life. Low scores indicate low satisfaction and high scores indicate high satisfaction.

Time frame
baseline, post-treatment and 3-month follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: